Topics

Mynosys Cellular Devices, Inc. Company Profile

09:25 EDT 23rd October 2019 | BioPortfolio

California-based Mynosys Cellular Devices is a global ophthalmic technology company dedicated to providing surgeons with innovative solutions that enable procedural excellence. Developers of the U.S. and internationally approved Zepto® Precision Cataract Surgery platform, the company is committed to developing high-quality solutions to assist physicians in delivering the best care to patients.


News Articles [731 Associated News Articles listed on BioPortfolio]

Mynosys Cellular Devices secures $25 million investment from Decheng Capital

Mynosys Cellular Devices, manufacturer of the Zepto cataract surgery device, today announced it finalized a $25 million financing round, led by Decheng Capital, and named veteran ophthalmology industr...

Mynosys Cellular Devices, Inc. Secures $25 Million Investment From Decheng Capital; Names Veteran Ophthalmic Executive Rob Thornhill as CEO

Company Expands Board of Directors Mynosys Cellular Devices, Inc., manufacturer of the Zepto® cataract surgery device, today announced it finalized a $25 million financing round, led by Decheng Cap...

IRW-News: Aequus Pharmaceuticals: Aequus liefert Zepto Capsulotomy System an Kensington Eye Institute und verlängert Vertriebsabkommen mit Mynosys

IRW-PRESS: Aequus Pharmaceuticals: Aequus liefert Zepto Capsulotomy System an Kensington Eye Institute und verlängert Vertriebsabkommen mit Mynosys Aequus liefert Zepto Capsulotomy System an Kensi...

Reversing Age-Related Vision Loss Using Cellular Reprogramming

Today, we want to draw attention to a new study that shows how partial cellular reprogram

Mitochondrial permeability plays a key role in aging, recovery from ischemic injury

(Massachusetts General Hospital) The ability of molecules to pass through the membrane of mitochondria -- the cellular structures that convert nutrients into energy -- may determine whether or not aut...

Rimidi, BodyTrace Partner to Provide Cellular-Enabled Scales to Heart Failure Patients

Rimidi has partnered with BodyTrace, a cellular technology company, to provide cellular-enabled scales to heart failure patients who are remotely monitored by their clinicians using Rimidi’s sof...

Partial Cellular Reprogramming to Reverse Cellular Aging

We have talked about the potential

Pop Goes the Synthetic Cellular Control Switch

Synthetic biologists have built a modular, tunable protein switch that can sense environmental stimuli and respond by modifying cell functions such as the control of gene expression, the management of...

Drugs and Medications [54 Associated Drugs and Medications listed on BioPortfolio]

Anticoagulant citrate dextrose a acd-a [arteriocyte medical systems, inc.]

Anticoagulant Citrate Dextrose Solution,Solution A, USP

Acd [terumo bct ltd]

Anticoagulant Citrate Dextrose Solution USP (ACD) Solution A

Haemonetics anticoagulant sodium citrate [haemonetics corporation]

Haemonetics Anticoagulant Sodium Citrate

Haemonetics anticoagulant citrate dextrose solution [haemonetics corporation]

Haemonetics Anticoagulant Citrate Dextrose Solution

Oxygen [intermountain home care]

Oxygen

PubMed Articles [1331 Associated PubMed Articles listed on BioPortfolio]

Protein-based parts and devices that respond to intracellular and extracellular signals in mammalian cells.

Synthetic biology aims to rewire cellular activities and functionality by implementing genetic circuits with high biocomputing capabilities. Recent efforts led to the development of smart sensing inte...

Laser printing-enabled direct creation of cellular heterogeneity in lab-on-a-chip devices.

Lab-on-a-chip devices, capable of culturing living cells in continuously perfused, micrometer-sized channels, have been intensively investigated to model physiological microenvironments for cell-relat...

Translating Minimally Invasive Glaucoma Surgery Devices.

Glaucoma is the leading cause of irreversible blindness with over 70 million people affected worldwide. The surgical management of glaucoma aims to lower intraocular pressure by increasing aqueous out...

Perspectives for Progress - A Framework to Evaluate Devices that Assess Physical Behavior.

Body-worn devices that estimate physical behavior have tremendous potential to address key research gaps. However, there is no consensus on how devices and processing methods should be developed and e...

Endothelialization of cardiovascular devices.

Blood-contacting surfaces of cardiovascular devices are not biocompatible for creating an endothelial layer on them. Numerous research studies have mainly sought to modify these surfaces through physi...

Clinical Trials [2205 Associated Clinical Trials listed on BioPortfolio]

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)

Dendritic cell-based cellular vaccine for tumor therapy has shown efficacy. This study is designed to perform a personalized clinical trial by first analyzing the expression of tumor assoc...

Mitochondrial Bioenergetics and Role in Cellular Damage in Ischemic Myocardium

Cardiac ischemia is a common pathological condition, known to elicit multiple pathological processes at the cellular level. One of the most affected is thought to be cellular metabolism, k...

Coated Devices to Decrease Infection in the Intensive Care Unit

Pilot explanatory, randomized, open label, controlled trial. Critically ill patients which will demand placement of invasive devices for organ support (endotracheal tube, central venous ca...

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

The purpose of this study is to evaluate the potential clinical benefit of prophylactic cytomegalovirus (CMV)-specific adoptive cellular therapy following T cell depleted allogeneic hemato...

Clinical Trial of Autologous Tcm Immunotherapy in ICC

The prime purpose of this trial is to evaluate the Progression Free survival and two-year survival of combining autologous Tcm cellular immunotherapy and traditional therapy in intrahepati...

Companies [1426 Associated Companies listed on BioPortfolio]

Mynosys Cellular Devices, Inc.

California-based Mynosys Cellular Devices is a global ophthalmic technology company dedicated to providing surgeons with innovative solutions that enable procedural excellence. Developers of the U.S....

Alces Technology, Inc.

Alces Technology develops innovative tools, techniques, and applications of microfabrication for academic, medical, and industrial laboratories. Our potential customers include researchers interested ...

General Devices

General Devices, a leader in advanced Telemedicine and Communications products for Emergency Medical Services, Emergency Departments and Public Safety, providing solutions for voice, telemetry, patien...

Cellular Research, Inc.

Cellular Research, Inc. is a biotechnology research and development company founded by innovators from Silicon Valley and Stanford University whose mission is to develop revolutio...

U.S. Cellular

U.S. Cellular is the fifth-largest full-service wireless carrier in the United States, providing national network coverage and industry-leading innovations designed to elevate the...

More Information about "Mynosys Cellular Devices, Inc." on BioPortfolio

We have published hundreds of Mynosys Cellular Devices, Inc. news stories on BioPortfolio along with dozens of Mynosys Cellular Devices, Inc. Clinical Trials and PubMed Articles about Mynosys Cellular Devices, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mynosys Cellular Devices, Inc. Companies in our database. You can also find out about relevant Mynosys Cellular Devices, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...


Corporate Database Quicklinks



Searches Linking to this Company Record